Evotec AG has achieved an important milestone in its TargetAD Alzheimer’s collaboration with Janssen Pharmaceuticals, transitioning a project into further drug discovery development.      The companies entered the collaboration in October 2013 to develop new drugs for Alzheimer’s disease. Janssen has the right to internalize selected targets and therapeutic candidates and progress them into preclinical and clinical development. Janssen funds target drug discovery research via a com...